(IN BRIEF) Evotec SE announced it has received a US$ 25 million payment from Bristol Myers Squibb, marking progress in their joint neuroscience partnership focused on neurodegenerative diseases. The milestone payment will further advance the companies’ preclinical pipeline and research … Read the full press release
Posted in Business, Germany, Healthcare, Investment, News, Pharma & Biotech, Science, Technology
Tagged biotechnology, BMS-986419, Bristol-Myers Squibb, clinical trials, Cord Dohrmann, disease-modifying therapies, drug discovery, Evotec and Bristol Myers Squibb Advance Neuroscience Collaboration with New Funding Milestone, Evotec SE, EVT8683, milestone payment, neurodegenerative diseases, neuroscience, neuroscience collaboration, neuroscience research, pharmaceutical innovation, preclinical research, strategic partnership, translational medicine
(IN BRIEF) The Helsinki Proteomics Center, a joint effort between HiLIFE’s Institute of Biotechnology and the Faculty of Medicine at the University of Helsinki, is enhancing Finland’s proteomics research capacity with the installation of three Thermo Scientific Orbitrap Astral and … Read the full press release
Posted in Business, Education, Financial, Finland, Industrial, Infrastructure & Utilities, Investment, Management, Marketing, News, Pharma & Biotech, Science, Technology
Tagged biobanks, Biocenter Finland, Faculty of Medicine, Finland life sciences, Helsinki Proteomics Center, HiLIFE, Institute of Biotechnology, Markku Varjosalo, Orbitrap Astral, Orbitrap Astral Zoom, partnership, patient registries, personalized medicine, protein interactions, proteomics, Research Council of Finland, structural biology, Thermo Scientific, translational medicine, University of Helsinki, XL-MS
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?